Research activities in healthcare have changed significantly in recent years. There has been a paradigm shift away from blockbusters drugs to a more personalized medicine approach as makers increasingly focus on formulating drugs based on the individual’s unique genome and immune response.
Personalized medicines have gained significant popularity because they enable the medical profession to provide customized treatment to patients. Customized treatment is based on the genetic as well as medical profile of a patient.
The increasing knowledge about the molecular causes of diseases is driving the demand for more targeted and effective nanotechnology-enabled drug delivery therapies. According to a new report by Infiniti Research, the nanotechnology drug delivery market in the United States is predicted to grow at a compound annual growth rate (CAGR) of 84.79% through 2016. Infiniti Research also forecasts that the global nanotechnology drug delivery market is expected to grow at a 73.97% CAGR through 2016.